Øystein Åmellem, PhD

Placeholder Person Graphic
Thermo Fisher Scientific
Oystein Amellem, PhD, has held leadership positions in research and development, product management, and business for over 21 years at Thermo Fisher Scientific. Oystein is responsible for development and commercialization of products and services, including the cell therapy market. His training is in the field of molecular cell biology and he received his PhD from the University of Oslo. Oystein’s academic career focused on the study of physiological and molecular mechanisms of tumor cell growth and involved investigating the method of actions for a novel group of anticancer compounds developed by Norsk Hydro.